These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 28068465

  • 1. One-Year Developmental Outcomes for Infants of Mothers With Bipolar Disorder.
    Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Sit DK, Wisner KL.
    J Clin Psychiatry; 2017; 78(8):1083-1090. PubMed ID: 28068465
    [Abstract] [Full Text] [Related]

  • 2. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Dills JL, Sit DK, Hanusa BH, Wisner KL.
    J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
    [Abstract] [Full Text] [Related]

  • 3. Prenatal antipsychotic exposure and neuromotor performance during infancy.
    Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport DJ.
    Arch Gen Psychiatry; 2012 Aug; 69(8):787-94. PubMed ID: 22474072
    [Abstract] [Full Text] [Related]

  • 4. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight.
    Frank DA, Jacobs RR, Beeghly M, Augustyn M, Bellinger D, Cabral H, Heeren T.
    Pediatrics; 2002 Dec; 110(6):1143-52. PubMed ID: 12456912
    [Abstract] [Full Text] [Related]

  • 5. Mood symptoms in pregnant and postpartum women with bipolar disorder: a naturalistic study.
    Driscoll KE, Sit DKY, Moses-Kolko EL, Pinheiro E, Yang A, Ciolino JD, Eng HF, Luther JF, Clark CT, Wisniewski SR, Wisner KL.
    Bipolar Disord; 2017 Jun; 19(4):295-304. PubMed ID: 28665044
    [Abstract] [Full Text] [Related]

  • 6. Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes.
    Wisner KL, Sit D, O'Shea K, Bogen DL, Clark CT, Pinheiro E, Yang A, Ciolino JD.
    J Affect Disord; 2019 Jan 15; 243():220-225. PubMed ID: 30248632
    [Abstract] [Full Text] [Related]

  • 7. Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.
    Singer LT, Moore DG, Min MO, Goodwin J, Turner JJ, Fulton S, Parrott AC.
    Neurotoxicol Teratol; 2016 Jan 15; 54():22-8. PubMed ID: 26806601
    [Abstract] [Full Text] [Related]

  • 8. Prenatal lead and cadmium co-exposure and infant neurodevelopment at 6 months of age: the Mothers and Children's Environmental Health (MOCEH) study.
    Kim Y, Ha EH, Park H, Ha M, Kim Y, Hong YC, Kim EJ, Kim BN.
    Neurotoxicology; 2013 Mar 15; 35():15-22. PubMed ID: 23220728
    [Abstract] [Full Text] [Related]

  • 9. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine.
    Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W, Arria A, Huestis M, Strauss A, Della Grotta S, Dansereau LM, Lin H, Lester BM.
    Neurotoxicol Teratol; 2011 Mar 15; 33(1):176-84. PubMed ID: 21256431
    [Abstract] [Full Text] [Related]

  • 10. Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.
    Wouldes TA, Lagasse LL, Huestis MA, Dellagrotta S, Dansereau LM, Lester BM.
    Neurotoxicol Teratol; 2014 Mar 15; 42():77-84. PubMed ID: 24566524
    [Abstract] [Full Text] [Related]

  • 11. Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents.
    Salazar de Pablo G, Guinart D, Cornblatt BA, Auther AM, Carrión RE, Carbon M, Jiménez-Fernández S, Vernal DL, Walitza S, Gerstenberg M, Saba R, Lo Cascio N, Brandizzi M, Arango C, Moreno C, Van Meter A, Correll CU.
    J Child Adolesc Psychopharmacol; 2020 May 15; 30(4):222-234. PubMed ID: 32083495
    [Abstract] [Full Text] [Related]

  • 12. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A, Ciolino JD, Pinheiro E, Rasmussen-Torvik LJ, Sit DKY, Wisner KL.
    J Clin Psychiatry; 2017 May 15; 78(5):605-611. PubMed ID: 28570796
    [Abstract] [Full Text] [Related]

  • 13. Stunting and wasting are associated with poorer psychomotor and mental development in HIV-exposed Tanzanian infants.
    McDonald CM, Manji KP, Kupka R, Bellinger DC, Spiegelman D, Kisenge R, Msamanga G, Fawzi WW, Duggan CP.
    J Nutr; 2013 Feb 15; 143(2):204-14. PubMed ID: 23256148
    [Abstract] [Full Text] [Related]

  • 14. Postpartum maternal mental health is associated with cognitive development of HIV-exposed infants in Zimbabwe: a cross-sectional study.
    Mebrahtu H, Simms V, Chingono R, Mupambireyi Z, Weiss HA, Ndlovu P, Malaba R, Cowan FM, Sherr L.
    AIDS Care; 2018 Jun 15; 30(sup2):74-82. PubMed ID: 29848008
    [Abstract] [Full Text] [Related]

  • 15. Neurodevelopmental effects of prenatal exposure to psychotropic medications.
    Gentile S.
    Depress Anxiety; 2010 Jul 15; 27(7):675-86. PubMed ID: 20583298
    [Abstract] [Full Text] [Related]

  • 16. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
    Gustafsson HC, Goodman SH, Feng T, Choi J, Lee S, Newport DJ, Knight B, Pingeton B, Stowe ZN, Monk C.
    Dev Psychopathol; 2018 Aug 15; 30(3):773-785. PubMed ID: 30068426
    [Abstract] [Full Text] [Related]

  • 17. Mothers with and without bipolar disorder and their infants: group differences in mother-infant interaction patterns at three months postpartum.
    Anke TMS, Slinning K, Moe V, Brunborg C, Siqveland TS, Skjelstad DV.
    BMC Psychiatry; 2019 Sep 18; 19(1):292. PubMed ID: 31533800
    [Abstract] [Full Text] [Related]

  • 18. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
    Hanley GE, Brain U, Oberlander TF.
    Early Hum Dev; 2013 Aug 18; 89(8):519-24. PubMed ID: 23384962
    [Abstract] [Full Text] [Related]

  • 19. Prenatal exposure to organohalogen compounds and children's mental and motor development at 18 and 30 months of age.
    Ruel MVM, Bos AF, Soechitram SD, Meijer L, Sauer PJJ, Berghuis SA.
    Neurotoxicology; 2019 May 18; 72():6-14. PubMed ID: 30664974
    [Abstract] [Full Text] [Related]

  • 20. A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.
    Sajatovic M, Tatsuoka C, Cassidy KA, Klein PJ, Fuentes-Casiano E, Cage J, Aebi ME, Ramirez LF, Blixen C, Perzynski AT, Bauer MS, Safren SA, Levin JB.
    J Clin Psychiatry; 2018 Sep 25; 79(6):. PubMed ID: 30256551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.